Inventor

FALOTICO ROBERT

US49 patents

⚠️ This page may combine multiple inventors who share the name “FALOTICO ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FALOTICO ROBERT

CORDIS CORP

Coated medical devices for the prevention and treatment of vascular disease

Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent

Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent

Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent

Coated medical devices for the treatment of vulnerable plaque

Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury

Drug/drug delivery systems for the prevention and treatment of vascular disease

Antithrombotic coating for drug eluting medical devices

Medical devices, drug coatings and methods for maintaining the drug coatings thereon

Implantable structures for local vascular delivery of cladribine in combination with rapamycin for restenosis

Drug combination useful for prevention of restenosis

Injectable formulations of taxanes for cad treatment

Solution formulations of sirolimus and its analogs for CAD treatment

Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury

Adhesion promoting primer for coated surfaces

Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury

Solution formulations of sirolimus and its analogs for CAD treatment

ORTHO PHARMA CORP

Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties

Substituted 5,6-dialkoxyquinazoline derivatives

5,6-dialkoxy-4-imino-2(1H)quinazolinone derivatives

Substituted thienopyrans as antihypertensive agents

Substituted 3-(4-phenyl-1-piperazinyl)alkylquinazolin-2,4-(1H,3H) diones, methods of preparation, compositions and method of use

Substituted thienopyrans as antihypertensive agents

Substituted thienopyrans

Substituted thienopyrans as antihypertensive agents

Substituted quinazoline-3-oxides providing pharmacological activity

Substituted quinazolinediones

6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides

4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties

4-alkyl-5,6-methylenedioxy-2-1[H]-quinazolinones useful as cardiotonic agents

6-7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides

2,2,4-trialkyl-1,2-dihydroquinazoline-3-oxides

Substituted thienopyrans as antihypertensive agents

FALOTICO ROBERT

Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease

Drug-eluting articles with improved drug release profiles

E beam sterilization of medical devices comprising bioactive coating

Drug/drug delivery systems for the prevention and treatment of vascular disease

Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury

Injectable formulations of taxanes for cad treatment

Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury

Intraluminal medical devices in combination with therapeutic agents

DAVE VIPUL

Extraction of solvents from drug containing polymer reservoirs

Adhesion promoting temporary mask for coated surfaces

WYETH LLC

Local vascular delivery of probucol in combination with sirolimus

Local vascular delivery of sirolimus to prevent restenosis following vascular injury

(unassigned)

Stent containing rapamycin or its analogs using a modified stent

CORDIS CORPORTATION

Antiinflammatory drug and delivery device

COOK DAVID

Therapeutic agent elution control process

WRIGHT CAROL

Methods and devices for delivering therapeutic agents to target vessels